# AKYNZEO
> **NDA210493** · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2018-04-19
## Drug
- **FDA Application Number:** NDA210493
- **Application type:** New Drug Application
- **Brand name:** AKYNZEO
- **Generic name:** FOSNETUPITANT AND PALONOSETRON
- **Active ingredients:** FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HELSINN HLTHCARE
- **Manufacturer:** Helsinn Therapeutics (U.S.), Inc.
- **First approval:** 2018-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210493)
---
*AI Analytics · CC0 1.0*